TITAN PHARMACEUTICALS INC's ticker is TTNP and the CUSIP is 888314101. A total of 3 filers reported holding TITAN PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $116,000 | -19.4% | 35,092 | -2.7% | 0.05% | -19.4% |
| Q4 2016 | $144,000 | -60.4% | 36,072 | -41.7% | 0.06% | -60.0% |
| Q3 2016 | $364,000 | +21.3% | 61,828 | -1.3% | 0.16% | +7.6% |
| Q1 2016 | $300,000 | +7.9% | 62,628 | +0.1% | 0.14% | +13.4% |
| Q4 2015 | $278,000 | +14.4% | 62,592 | +2.6% | 0.13% | +6.7% |
| Q3 2015 | $243,000 | -9.7% | 61,004 | -81.8% | 0.12% | +12.3% |
| Q2 2015 | $269,000 | +13.0% | 335,699 | 0.0% | 0.11% | +34.2% |
| Q1 2015 | $238,000 | +53.5% | 335,699 | 0.0% | 0.08% | +58.0% |
| Q4 2014 | $155,000 | -41.1% | 335,699 | -29.0% | 0.05% | -43.2% |
| Q3 2014 | $263,000 | -28.9% | 473,109 | +0.3% | 0.09% | -26.7% |
| Q2 2014 | $370,000 | +12.5% | 471,859 | -3.9% | 0.12% | +22.4% |
| Q1 2014 | $329,000 | +11.9% | 490,832 | +0.8% | 0.10% | +11.4% |
| Q4 2013 | $294,000 | -10.1% | 486,717 | 0.0% | 0.09% | -13.7% |
| Q3 2013 | $327,000 | +48.6% | 486,717 | +1.9% | 0.10% | +27.5% |
| Q2 2013 | $220,000 | – | 477,687 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|